HEADER TRANSFERASE 28-NOV-20 7B31 TITLE MST3 IN COMPLEX WITH COMPOUND MRIA9 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE 24; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAMMALIAN STE20-LIKE PROTEIN KINASE 3,MST-3,STE20-LIKE COMPND 5 KINASE MST3; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: STK24, MST3, STK3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE INHIBITORS, STRUCTURE-BASED DRUG DESIGN, SIK2 INHIBITOR, KEYWDS 2 STRUCTURAL GENOMICS CONSORTIUM, SGC, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR R.TESCH,M.RAK,A.C.JOERGER,S.KNAPP,STRUCTURAL GENOMICS CONSORTIUM AUTHOR 2 (SGC) REVDAT 4 31-JAN-24 7B31 1 REMARK REVDAT 3 07-JUL-21 7B31 1 JRNL REVDAT 2 23-JUN-21 7B31 1 JRNL REVDAT 1 16-DEC-20 7B31 0 JRNL AUTH R.TESCH,M.RAK,M.RAAB,L.M.BERGER,T.KRONENBERGER,A.C.JOERGER, JRNL AUTH 2 B.T.BERGER,I.ABDI,T.HANKE,A.POSO,K.STREBHARDT,M.SANHAJI, JRNL AUTH 3 S.KNAPP JRNL TITL STRUCTURE-BASED DESIGN OF SELECTIVE SALT-INDUCIBLE KINASE JRNL TITL 2 INHIBITORS. JRNL REF J.MED.CHEM. V. 64 8142 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 34086472 JRNL DOI 10.1021/ACS.JMEDCHEM.0C02144 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.86 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 33008 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.179 REMARK 3 R VALUE (WORKING SET) : 0.177 REMARK 3 FREE R VALUE : 0.212 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.820 REMARK 3 FREE R VALUE TEST SET COUNT : 1590 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.86 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2865 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.47 REMARK 3 BIN R VALUE (WORKING SET) : 0.2232 REMARK 3 BIN FREE R VALUE SET COUNT : 124 REMARK 3 BIN FREE R VALUE : 0.2430 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2060 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 35 REMARK 3 SOLVENT ATOMS : 128 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.53 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.82 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.175 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): NULL ; NULL ; NULL REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : NULL NULL NULL NULL REMARK 3 ORIGIN FOR THE GROUP (A): -41.8773 -9.9253 12.1255 REMARK 3 T TENSOR REMARK 3 T11: 0.3042 T22: 0.3694 REMARK 3 T33: 0.2968 T12: -0.0816 REMARK 3 T13: -0.0372 T23: -0.0127 REMARK 3 L TENSOR REMARK 3 L11: 6.1473 L22: 3.6781 REMARK 3 L33: 6.6676 L12: -0.1664 REMARK 3 L13: -1.8873 L23: -0.9998 REMARK 3 S TENSOR REMARK 3 S11: -0.1215 S12: 0.3936 S13: -0.0109 REMARK 3 S21: -0.5460 S22: 0.2892 S23: -0.0386 REMARK 3 S31: 0.0454 S32: -0.3429 S33: -0.1385 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : NULL NULL NULL NULL REMARK 3 ORIGIN FOR THE GROUP (A): -25.3365 -3.9464 15.2235 REMARK 3 T TENSOR REMARK 3 T11: 0.2456 T22: 0.2110 REMARK 3 T33: 0.2322 T12: -0.0152 REMARK 3 T13: 0.0138 T23: -0.0089 REMARK 3 L TENSOR REMARK 3 L11: 2.3449 L22: 1.8504 REMARK 3 L33: 1.5022 L12: 1.1472 REMARK 3 L13: 0.7705 L23: 0.7671 REMARK 3 S TENSOR REMARK 3 S11: -0.0796 S12: 0.2909 S13: -0.1502 REMARK 3 S21: -0.2443 S22: 0.1070 S23: -0.1084 REMARK 3 S31: 0.0720 S32: -0.0138 S33: -0.0264 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : NULL NULL NULL NULL REMARK 3 ORIGIN FOR THE GROUP (A): -14.6131 7.4043 24.0180 REMARK 3 T TENSOR REMARK 3 T11: 0.1786 T22: 0.1873 REMARK 3 T33: 0.2264 T12: -0.0201 REMARK 3 T13: -0.0217 T23: -0.0147 REMARK 3 L TENSOR REMARK 3 L11: 1.8674 L22: 2.5459 REMARK 3 L33: 3.1339 L12: 0.5494 REMARK 3 L13: -0.0913 L23: -0.6046 REMARK 3 S TENSOR REMARK 3 S11: -0.0367 S12: 0.0468 S13: -0.0009 REMARK 3 S21: 0.0011 S22: 0.0235 S23: -0.1570 REMARK 3 S31: -0.0817 S32: 0.0038 S33: 0.0128 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.11 REMARK 3 ION PROBE RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7B31 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-NOV-20. REMARK 100 THE DEPOSITION ID IS D_1292112389. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-MAR-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00004 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33013 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 39.860 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 6.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.84 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 6.30 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3ZHP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.62 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN SOLUTION: 10 MG/ML IN BUFFER REMARK 280 25 MM HEPES PH 7.5, 200 MM NACL, 5% GLYCEROL, 0.5 MM TCEP. REMARK 280 RESERVOIR: 16% PEG 6000, 0.1M HEPES PH 7.0., VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 49.71450 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.53400 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 49.71450 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 29.53400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12750 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 3 REMARK 465 ARG A 4 REMARK 465 ALA A 5 REMARK 465 GLN A 6 REMARK 465 LEU A 7 REMARK 465 TRP A 8 REMARK 465 GLY A 9 REMARK 465 LEU A 10 REMARK 465 ALA A 11 REMARK 465 LEU A 12 REMARK 465 ASN A 13 REMARK 465 LYS A 14 REMARK 465 ARG A 15 REMARK 465 ARG A 16 REMARK 465 ALA A 17 REMARK 465 THR A 18 REMARK 465 LEU A 19 REMARK 465 PRO A 20 REMARK 465 HIS A 21 REMARK 465 PRO A 22 REMARK 465 GLY A 23 REMARK 465 GLY A 24 REMARK 465 SER A 25 REMARK 465 GLY A 179 REMARK 465 GLN A 180 REMARK 465 LEU A 181 REMARK 465 THR A 182 REMARK 465 ASP A 183 REMARK 465 THR A 184 REMARK 465 GLN A 185 REMARK 465 ILE A 186 REMARK 465 LYS A 187 REMARK 465 ARG A 188 REMARK 465 ASN A 189 REMARK 465 THR A 190 REMARK 465 PHE A 191 REMARK 465 VAL A 192 REMARK 465 GLY A 193 REMARK 465 ALA A 207 REMARK 465 HIS A 307 REMARK 465 HIS A 308 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 28 CG CD1 CD2 REMARK 470 LYS A 29 CG CD CE NZ REMARK 470 LYS A 41 CG CD CE NZ REMARK 470 LYS A 44 CG CD CE NZ REMARK 470 GLU A 71 CG CD OE1 OE2 REMARK 470 ASP A 74 CG OD1 OD2 REMARK 470 GLU A 75 CG CD OE1 OE2 REMARK 470 GLU A 124 CG CD OE1 OE2 REMARK 470 LYS A 151 CD CE NZ REMARK 470 SER A 206 OG REMARK 470 GLU A 228 CG CD OE1 OE2 REMARK 470 LYS A 238 CG CD CE NZ REMARK 470 LYS A 292 CG CD CE NZ REMARK 470 HIS A 304 CG ND1 CD2 CE1 NE2 REMARK 470 HIS A 305 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 39 -148.91 -112.20 REMARK 500 PHE A 47 -29.40 72.50 REMARK 500 ASP A 104 -124.00 48.60 REMARK 500 ARG A 155 -4.89 81.30 REMARK 500 ASP A 156 54.87 -146.19 REMARK 500 GLN A 205 27.99 49.16 REMARK 500 ASP A 209 -159.26 -135.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SQ8 A 401 DBREF 7B31 A 4 301 UNP Q9Y6E0 STK24_HUMAN 4 301 SEQADV 7B31 MET A 3 UNP Q9Y6E0 INITIATING METHIONINE SEQADV 7B31 ALA A 302 UNP Q9Y6E0 EXPRESSION TAG SEQADV 7B31 HIS A 303 UNP Q9Y6E0 EXPRESSION TAG SEQADV 7B31 HIS A 304 UNP Q9Y6E0 EXPRESSION TAG SEQADV 7B31 HIS A 305 UNP Q9Y6E0 EXPRESSION TAG SEQADV 7B31 HIS A 306 UNP Q9Y6E0 EXPRESSION TAG SEQADV 7B31 HIS A 307 UNP Q9Y6E0 EXPRESSION TAG SEQADV 7B31 HIS A 308 UNP Q9Y6E0 EXPRESSION TAG SEQRES 1 A 306 MET ARG ALA GLN LEU TRP GLY LEU ALA LEU ASN LYS ARG SEQRES 2 A 306 ARG ALA THR LEU PRO HIS PRO GLY GLY SER THR ASN LEU SEQRES 3 A 306 LYS ALA ASP PRO GLU GLU LEU PHE THR LYS LEU GLU LYS SEQRES 4 A 306 ILE GLY LYS GLY SER PHE GLY GLU VAL PHE LYS GLY ILE SEQRES 5 A 306 ASP ASN ARG THR GLN LYS VAL VAL ALA ILE LYS ILE ILE SEQRES 6 A 306 ASP LEU GLU GLU ALA GLU ASP GLU ILE GLU ASP ILE GLN SEQRES 7 A 306 GLN GLU ILE THR VAL LEU SER GLN CYS ASP SER PRO TYR SEQRES 8 A 306 VAL THR LYS TYR TYR GLY SER TYR LEU LYS ASP THR LYS SEQRES 9 A 306 LEU TRP ILE ILE MET GLU TYR LEU GLY GLY GLY SER ALA SEQRES 10 A 306 LEU ASP LEU LEU GLU PRO GLY PRO LEU ASP GLU THR GLN SEQRES 11 A 306 ILE ALA THR ILE LEU ARG GLU ILE LEU LYS GLY LEU ASP SEQRES 12 A 306 TYR LEU HIS SER GLU LYS LYS ILE HIS ARG ASP ILE LYS SEQRES 13 A 306 ALA ALA ASN VAL LEU LEU SER GLU HIS GLY GLU VAL LYS SEQRES 14 A 306 LEU ALA ASP PHE GLY VAL ALA GLY GLN LEU THR ASP THR SEQRES 15 A 306 GLN ILE LYS ARG ASN THR PHE VAL GLY THR PRO PHE TRP SEQRES 16 A 306 MET ALA PRO GLU VAL ILE LYS GLN SER ALA TYR ASP SER SEQRES 17 A 306 LYS ALA ASP ILE TRP SER LEU GLY ILE THR ALA ILE GLU SEQRES 18 A 306 LEU ALA ARG GLY GLU PRO PRO HIS SER GLU LEU HIS PRO SEQRES 19 A 306 MET LYS VAL LEU PHE LEU ILE PRO LYS ASN ASN PRO PRO SEQRES 20 A 306 THR LEU GLU GLY ASN TYR SER LYS PRO LEU LYS GLU PHE SEQRES 21 A 306 VAL GLU ALA CYS LEU ASN LYS GLU PRO SER PHE ARG PRO SEQRES 22 A 306 THR ALA LYS GLU LEU LEU LYS HIS LYS PHE ILE LEU ARG SEQRES 23 A 306 ASN ALA LYS LYS THR SER TYR LEU THR GLU LEU ILE ASP SEQRES 24 A 306 ALA HIS HIS HIS HIS HIS HIS HET SQ8 A 401 35 HETNAM SQ8 1-[(5-AZANYL-1,3-DIOXAN-2-YL)METHYL]-3-[2-CHLORANYL-4- HETNAM 2 SQ8 (3-FLUORANYLPYRIDIN-2-YL)PHENYL]-7-(METHYLAMINO)-1,6- HETNAM 3 SQ8 NAPHTHYRIDIN-2-ONE FORMUL 2 SQ8 C25 H23 CL F N5 O3 FORMUL 3 HOH *128(H2 O) HELIX 1 AA1 ASP A 31 LEU A 35 1 5 HELIX 2 AA2 ALA A 72 ASP A 74 5 3 HELIX 3 AA3 GLU A 75 GLN A 88 1 14 HELIX 4 AA4 ALA A 119 LEU A 123 1 5 HELIX 5 AA5 ASP A 129 GLU A 150 1 22 HELIX 6 AA6 LYS A 158 ALA A 160 5 3 HELIX 7 AA7 ALA A 199 LYS A 204 1 6 HELIX 8 AA8 SER A 210 GLY A 227 1 18 HELIX 9 AA9 HIS A 235 ASN A 246 1 12 HELIX 10 AB1 SER A 256 LEU A 267 1 12 HELIX 11 AB2 GLU A 270 ARG A 274 5 5 HELIX 12 AB3 THR A 276 LEU A 281 1 6 HELIX 13 AB4 HIS A 283 ALA A 290 1 8 HELIX 14 AB5 LYS A 292 TYR A 295 5 4 HELIX 15 AB6 LEU A 296 HIS A 306 1 11 SHEET 1 AA1 5 PHE A 36 LYS A 44 0 SHEET 2 AA1 5 GLU A 49 ASP A 55 -1 O LYS A 52 N LEU A 39 SHEET 3 AA1 5 VAL A 61 ASP A 68 -1 O ILE A 64 N PHE A 51 SHEET 4 AA1 5 LYS A 106 GLU A 112 -1 O LEU A 107 N ILE A 67 SHEET 5 AA1 5 TYR A 97 LYS A 103 -1 N TYR A 101 O TRP A 108 SHEET 1 AA2 3 GLY A 117 SER A 118 0 SHEET 2 AA2 3 VAL A 162 LEU A 164 -1 O LEU A 164 N GLY A 117 SHEET 3 AA2 3 VAL A 170 LEU A 172 -1 O LYS A 171 N LEU A 163 SITE 1 AC1 17 VAL A 50 ALA A 63 LYS A 65 ILE A 79 SITE 2 AC1 17 GLU A 82 ILE A 83 LEU A 86 ILE A 109 SITE 3 AC1 17 MET A 111 GLU A 112 LEU A 114 ALA A 160 SITE 4 AC1 17 ASN A 161 LEU A 163 ASP A 174 HOH A 531 SITE 5 AC1 17 HOH A 568 CRYST1 99.429 59.068 61.728 90.00 93.52 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010057 0.000000 0.000618 0.00000 SCALE2 0.000000 0.016930 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016231 0.00000